SBFM
Closed
Sunshine Biopharma Inc
1.45
+0.01 (+0.69%)
Last Update: 01 Jul 2025 23:07:00
Yesterday: 1.44
Day's Range: 1.43 - 1.49
Send
sign up or login to leave a comment!
When Written:
0.6509
Sunshine Biopharma Inc is a pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of various forms of cancer. The company's lead product candidate is Adva-27a, which is a small molecule drug that has shown promising results in preclinical studies for the treatment of pancreatic cancer, breast cancer, and other types of cancer.
Sunshine Biopharma Inc is headquartered in Montreal, Canada, and was founded in 2009. The company is publicly traded on the OTC Markets under the ticker symbol "SBFM".
In addition to Adva-27a, Sunshine Biopharma Inc is also developing other drug candidates, including Adva-28a, which is a derivative of Adva-27a that has shown potential for the treatment of drug-resistant cancer cells.
The company's mission is to develop innovative and effective cancer treatments that can improve the lives of patients and their families.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Sunshine Biopharma Inc is headquartered in Montreal, Canada, and was founded in 2009. The company is publicly traded on the OTC Markets under the ticker symbol "SBFM".
In addition to Adva-27a, Sunshine Biopharma Inc is also developing other drug candidates, including Adva-28a, which is a derivative of Adva-27a that has shown potential for the treatment of drug-resistant cancer cells.
The company's mission is to develop innovative and effective cancer treatments that can improve the lives of patients and their families.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








